Autologous immuno magnetically selected CD133+ stem cells in the treatment of no-option critical limb ischemia: clinical and contrast enhanced ultrasound assessed results in eight patients-Reference-Cited by-同舟云学术

Autologous immuno magnetically selected CD133+ stem cells in the treatment of no-option critical limb ischemia: clinical and contrast enhanced ultrasound assessed results in eight patients

Published:2015-11-03 Issue:1 Volume:13 Page:
ISSN:1479-5876
Container-title:Journal of Translational Medicine
language:en
Short-container-title:J Transl Med

Author:

Arici Vittorio,Perotti Cesare,Fabrizio Calliada,Del Fante Claudia,Ragni Franco,Alessandrino Francesco,Viarengo Gianluca,Pagani Michele,Moia Alessia,Tinelli Carmine,Bozzani Antonio

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12967-015-0697-4

Reference20 articles.

1. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, TASC II Working Group, Bell K, Caporusso J, Durand-Zaleski I, Komori K, Lammer J, Liapis C, Novo S, Razavi M, Robbs J, Schaper N, Shigematsu H, Sapoval M, White C, White J, Clement D, Creager M, Jaff M, Mohler E 3rd, Rutherford RB, Sheehan P, Sillesen H, Rosenfield K. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg. 2007;33(Suppl 1):S1–75.

2. Döbert N, Britten M, Assmus B, Berner U, Menzel C, Lehmann R, Hamscho N, Schächinger V, Dimmeler S, Zeiher AM, Grünwald F. Transplantation of progenitor cells after reperfused acute myocardial infarction: evaluation of perfusion and myocardial viability with FDG-PET and thallium SPECT. Eur J Nucl Med Mol Imaging. 2004;31:1146–51.

3. Young PP, Vaughan DE, Hatzopoulos AK. Biological properties of endothelial progenitor cells and their potential for cell therapy. Prog Cardiovasc Dis. 2007;49:421–9.

4. Losordo DW, Dimmeler S. Therapeutic angiogenesis and vasculogenesis for ischemic disease: part I: angiogenic cytokines. Circulation. 2004;109:2487–91.

5. Losordo DW, Dimmeler S. Therapeutic angiogenesis and vasculogenesis for ischemic disease: part II: cell-based therapies. Circulation. 2004;109:2692–7.

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LncRNA H19/miR-107 regulates endothelial progenitor cell pyroptosis and promotes flow recovery of lower extremity ischemia through targeting FADD;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-10

2. Immunomagnetic Delivery of Adipose-Derived Endothelial Progenitor Cells for the Repair of Renal Ischemia–Reperfusion Injury in a Rat Model;Bioengineering;2023-04-24

3. Traditional Applications of Magnetic Nanoparticles in Clinical Diagnostics and Therapeutics;SpringerBriefs in Molecular Science;2022-11-01

4. Endothelial colony-forming cell-derived exosomal miR-21-5p regulates autophagic flux to promote vascular endothelial repair by inhibiting SIPL1A2 in atherosclerosis;Cell Communication and Signaling;2022-03-12

5. Therapeutic Potential of Endothelial Progenitor Cells in Pulmonary Diseases;American Journal of Respiratory Cell and Molecular Biology;2021-11